Alps Advisors Inc Syndax Pharmaceuticals Inc Transaction History

Alps Advisors Inc

  • $14.1 Billion
  • Q1 2024

A detailed history of Alps Advisors Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 59,924 shares of SNDX stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59,924
Previous 48,126 24.51%
Holding current value
$1.27 Million
Previous $1.04 Million 37.12%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$19.71 - $24.57 $232,538 - $289,876
11,798 Added 24.51%
59,924 $1.43 Million
Q4 2023

Feb 14, 2024
SELL
$11.39 - $21.67 $35,422 - $67,393
-3,110 Reduced 6.07%
48,126 $1.04 Million
Q3 2023

Nov 14, 2023
BUY
$14.52 - $21.77 $9,452 - $14,172
651 Added 1.29%
51,236 $743,000
Q2 2023

Aug 14, 2023
BUY
$19.35 - $22.31 $106,347 - $122,615
5,496 Added 12.19%
50,585 $1.06 Million
Q1 2023

May 10, 2023
SELL
$20.66 - $28.98 $6,549 - $9,186
-317 Reduced 0.7%
45,089 $952,000
Q4 2022

Feb 14, 2023
BUY
$20.64 - $26.24 $300,394 - $381,896
14,554 Added 47.17%
45,406 $1.16 Million
Q3 2022

Nov 14, 2022
SELL
$18.51 - $24.79 $46,349 - $62,074
-2,504 Reduced 7.51%
30,852 $741,000
Q2 2022

Aug 11, 2022
SELL
$13.64 - $19.48 $316,175 - $451,546
-23,180 Reduced 41.0%
33,356 $642,000
Q1 2022

May 16, 2022
SELL
$14.84 - $22.15 $24,382 - $36,392
-1,643 Reduced 2.82%
56,536 $983,000
Q4 2021

Feb 09, 2022
SELL
$15.23 - $22.47 $21,535 - $31,772
-1,414 Reduced 2.37%
58,179 $1.27 Million
Q3 2021

Nov 15, 2021
SELL
$13.87 - $19.8 $54,758 - $78,170
-3,948 Reduced 6.21%
59,593 $1.14 Million
Q2 2021

Aug 11, 2021
BUY
$13.42 - $25.18 $852,720 - $1.6 Million
63,541 New
63,541 $1.09 Million
Q4 2018

Feb 04, 2019
SELL
$3.6 - $8.42 $148,780 - $347,981
-41,328 Closed
0 $0
Q3 2018

Oct 25, 2018
BUY
$6.33 - $8.08 $34,669 - $44,254
5,477 Added 15.28%
41,328 $334,000
Q2 2018

Aug 02, 2018
BUY
$6.93 - $14.63 $61,157 - $129,109
8,825 Added 32.65%
35,851 $252,000
Q2 2018

Jul 25, 2018
SELL
$6.93 - $14.63 $39,403 - $83,186
-5,686 Reduced 17.38%
27,026 $237,000
Q1 2018

May 01, 2018
BUY
$8.71 - $14.82 $49,525 - $84,266
5,686 Added 21.04%
32,712 $465,000
Q4 2017

Feb 05, 2018
BUY
$7.8 - $12.94 $40,115 - $66,550
5,143 Added 23.5%
27,026 $237,000
Q3 2017

Nov 03, 2017
BUY
$10.9 - $12.73 $238,524 - $278,570
21,883
21,883 $256,000

Others Institutions Holding SNDX

# of Institutions
195
Shares Held
90M
Call Options Held
353K
Put Options Held
207K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $1.2B
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email